In this webinar, you’ll hear from Paul Vauterin. He is currently CIO of Aelin Therapeutics, a biotech company leveraging targeted protein aggregation to develop an entirely new class of therapeutics aiming at hard-to-treat targets in cancer and infectious diseases. Paul is responsible for bioinformatics and data science activities, which are crucial elements of the company’s drug discovery and development platform.
And also, James Longden, Head of Discovery Biology at E-therapeutics, a biotech company that integrates computational power and biology to discover life-transforming RNAi medicines. James is focused on big data biology and machine learning to predict systems-wide changes driving the disease.